Strix Group’s (KETL) Buy Rating Reiterated at Canaccord Genuity

Share on StockTwits

Canaccord Genuity reaffirmed their buy rating on shares of Strix Group (LON:KETL) in a report released on Wednesday morning, Digital Look reports. The brokerage currently has a GBX 210 ($2.74) price target on the stock.

KETL has been the topic of a number of other research reports. Peel Hunt reissued a buy rating and set a GBX 175 ($2.29) price objective on shares of Strix Group in a research report on Wednesday. Shore Capital reissued a buy rating on shares of Strix Group in a research report on Wednesday.

KETL stock opened at GBX 175.40 ($2.29) on Wednesday. The stock has a market capitalization of $333.26 million and a PE ratio of 15.12. The company’s 50-day moving average is GBX 165.77 and its 200-day moving average is GBX 161.84. Strix Group has a 1 year low of GBX 128 ($1.67) and a 1 year high of GBX 182 ($2.38).

The business also recently disclosed a dividend, which will be paid on Friday, October 25th. Stockholders of record on Thursday, September 26th will be given a dividend of GBX 2.60 ($0.03) per share. The ex-dividend date of this dividend is Thursday, September 26th. This represents a dividend yield of 1.54%. Strix Group’s dividend payout ratio (DPR) is presently 0.60%.

Strix Group Company Profile

Strix Group Plc manufactures and sells kettle safety controls and other components worldwide. The company offers thermostatic controls, cordless interfaces, water jugs, and filters. It also provides water heating, temperature and steam-management devices, such as steam boilers, instant flow heaters, and turbo toasters.

Featured Story: Earnings Reports

Receive News & Ratings for Strix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strix Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dunelm Group  Stock Rating Upgraded by Peel Hunt
Dunelm Group Stock Rating Upgraded by Peel Hunt
Barclays Downgrades Ferrexpo  to Underweight
Barclays Downgrades Ferrexpo to Underweight
UBS Group Reaffirms “Neutral” Rating for Halma
UBS Group Reaffirms “Neutral” Rating for Halma
Schneider National  Raised to Buy at UBS Group
Schneider National Raised to Buy at UBS Group
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Sunoco  Upgraded at ValuEngine
Sunoco Upgraded at ValuEngine


 
© 2006-2019 Zolmax.